8 August 2018

Stein Schalkwijk, Angela Colbers and David Burger of the department of Pharmacy developed the Toolkit “Pregnant and breastfeeding women” in cooperation with Mark Mirochnick (Boston University, MA, USA) as a part of “Toolkit for research and development of paediatric antiretroviral drugs and formulations”.

In 2016, an estimated 2.1 million children and 17.8 million women were living with HIV, and yet antiretroviral drug formulations for treating HIV among infants, children, adolescents and pregnant and breastfeeding women remain limited. Although well established legislative and regulatory frameworks support and stimulate the process of developing medicines for children, this process needs to be accelerated to ensure that much-needed antiretroviral formulations are available for children, especially those living in low- and middle-income countries.
 
This toolkit identifies the challenges and outlines possible solutions for promoting and accelerating timely and high-quality research and development of antiretroviral drug formulations suitable for infants, children, adolescents and pregnant and breastfeeding women. Although this toolkit focuses on HIV medicines, many of the principles outlined here can be applied to treatments for other diseases affecting pregnant women and children.
 
The toolkit can be found: https://globalhealthtrainingcentre.tghn.org/research-toolkit-paediatric-antiretroviral-drug-and-formulation-development/
Registration is free of charge.

This research is conducted within the theme Infectious diseases and global health.
 

Related news items


The real impact of menstrual complaints on work and school productivity

8 July 2019

Menstrual period symptoms may be linked to nearly nine days of lost productivity every year, through presenteeism, suggests the largest study of its kind, published in the journal BMJ Open. But the real impact on women and society is underestimated and poorly appreciated, say the researchers.

read more

Walking for science Research by Radboud university medical center and Radboud University during the Vierdaagse (Four Day Marches)

5 July 2019

The Vierdaagse is a unique opportunity to conduct research into physical activity and healthy lifestyle.

read more

Prostate cancer theranostics imaging, surgical guidance, and targeted photodynamic therapy

5 July 2019

In Theranostics, Mark Rijpkema and colleagues present the development of a novel multimodal tracer that targets both preoperative imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing prostate cancer.

read more

Ronald van Rij appointed Professor of Experimental Virology

4 July 2019

Ronald van Rij, theme Infectious diseases and global health, has been appointed Professor of Experimental Virology at Radboud University / Radboud university medical center with effect from 1 July 2019.

read more

Effects of prophylactic haloperidol on long-term quality of life in ICU Patients

4 July 2019

In Anesthesiology, Paul Rood, Marieke Zegers and Mark van den Boogaard described that prophylactic haloperidol use does not affect long-term quality of life in critically ill patients at high risk for delirium.

read more

Radboud Campus unravels the thirty-something brain

4 July 2019

This summer, Radboud University, Radboudumc and the Max Planck Institute for Psycholinguistics will unravel the thirty-something brain. The aim of the Healthy Brain Study is to improve understanding of how the human brain works.

read more